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Abstracts / International Journal of Surgery 12 (2014) S13eS117 S19no or mild pain in recovery. Similarly the patients who experiencedmild to
moderate pain on days 1, 2 and 3 was 86%, 92% and 93 % while severe pain
was 14% , 8% and 7% respectively. A signiﬁcant number of patients did not
require any additional pain relief 73% Vs 27% while only 4/36 reported of
nausea only. The overall patient satisfaction regarding pain control was
100%, which helped achieve a discharge of over 90% of patients by day 3.
Conclusions: The use of patient controlled wound soakers is a safe,
effective and reliable method of post-op pain control following breast
reconstruction.
*Median.
1187: RETROSPECTIVE ANALYSIS OF RE-EXCISION RATES IN BREAST
CANCER SURGERY
Michael Ding*,1, Roderick Prawiradiradja 2, Mark Yun 1, Ernest Chew4,
Habib Tafazal 3. 1Heart of England NHS Trust, Birmingham, UK; 2NHS,
London, UK; 3NHS, Birmingham, UK; 4University College London, London, UK.
Introduction: It is important to obtain sufﬁcient margins when per-
forming curative breast surgery. Surgery for re-excision is associated with
increased morbidity and postoperative complications. Our aim was to
evaluate the rate of re-excisions for inadequate margins in our unit.
Methods: A retrospective study was conducted on all surgeries performed
for breast cancer between 1/8/12 and 1/3/13 at a District General Hospital.
Data was obtained from histopathology and electronic patient records.
Results: 132 patients were included in the study. 77 WLE (Wide Local
Excision) and 55 mastectomies were performed with intraoperative
radiological margins assessment. 54.5% (n¼42) WLE were wire-guided.
The overall re-excision rate was 29.9% (n¼23). 23.8 % (n¼10) wire guided
procedures resulted in reexcision and 37.1% (n¼13) nonwire-guided un-
derwent re-excision. 7 WLE resulted in mastectomy. 34 patients had
margins of <2mm and 64.7% (n¼22) underwent re-excision.
Conclusions: Re-excision rates for breast conserving surgery remains high
despite intraoperative radiological margin assessment.
1361: LYMPHOSCINTIGRAM AND SENTINEL NODE BIOPSY: DOWE NEED
A PICTURE?
Somashree Chatterji*, Grit Dabritz. North Manchester General Hospital,
Manchester, UK.
Introduction: There is decreasing evidence supporting the use of lym-
phoscintigrams for sentinel node identiﬁcation in breast cancer. We aimed
to show if there was agreement between the number of nodes identiﬁed
pre-operatively on lymphoscintigram with that identiﬁed with dye or
gamma probe intraoperatively.
Methods: All patients of the lead consultant who had undergone a lym-
phoscintigram over a two-year period were identiﬁed using PACS. Images
and notes were analysed to compare pre- and intra-operative ﬁndings.
Results: 74 patients were identiﬁed, of which 93.2% (69) had lympho-
scintigrams identifying nodes. Of these, 18.9% (14) were positive on his-
tology. 48.6% (36) of patients who had nodes identiﬁed on
lymphoscintigram were found to have an equal number on histology.
28.4% (21) had fewer nodes identiﬁed pre-operatively than on histology,
while 23% (17) had more nodes identiﬁed pre-operatively than were
positive on histology. The false negative rate was 0.07%.
Conclusions: Our ﬁndings did not support use of routine lymphoscintig-
raphy. Current recommendations supports its use in previous axillary
surgery, and our rate of accurate correlation (48%) was poor compared
with blinded studies. The next stage would be to extend the scope of the
audit across the unit. A prospective, blinded study would better determine
causality.
1387: AN EVOLUTION IN THE SURGICAL MANAGEMENT OF PATIENTS
WITH SENTINEL LYMPH NODE METASTASES
Aisling Nic An Riogh*,1,2, Maeve McAllister 1,2, Michael J. Kerin 1,2,
Edel M. Quinn 1,2, Karl J. Sweeney 1,2. 1Division of Surgery, National
University of Ireland, University College Galway, Ireland; 2Breastcheck
Western Unit, Galway, Ireland.
Introduction: Until recently, detection of sentinel lymph node (SLN)
metastases mandated axillary clearance (AC) followed by adjuvant
chemotherapy. There is increasing evidence that this is no longer the
case. We aim to assess the impact of this evidence on our institution's
practice1.Methods: A retrospective cohort study of patients with SLN metastases
between January 2011-December 2012 was undertaken. Data was
collected from prospective databases, hospital records and pathology
reports.
During the study period, 103 patients had SLN metastases. The
decision regarding further management was made at multidisciplinary
meetings. 57 patients progressed to AC. Of these, 22 had chemotherapy
prior to completion AC. Nine of these patients had further axillary
metastases, of whom 3 showed partial/complete chemotherapy
response.
Results: There was no statistically signiﬁcant difference in treatment
duration between patients who had chemotherapy pre or post AC.
Nor was there any difference in the treatment duration of those
who required post-operative radiotherapy and those who didn't,
(p¼0.67 in the radiotherapy group, p¼0.95 in the no radiotherapy
group).
Conclusions: In conclusion, we have observed a radical change in the
management of patients with SLN metastases. There has been a move
away from immediate AC following the identiﬁcation of SLN metastases to
chemotherapy alone or combined with completion AC.
1401: SHOULDWE BE DOING OSNA INTRAOPERATIVE ASSESSMENT FOR
PATIENTS UNDERGOING MASTECTOMY FOR DCIS?
Mohammed Elniel*, Shamaela Waheed. The Royal Marsden Hospital,
London, UK.
Introduction: Invasive disease may be found at mastectomy for DCIS, a
sentinel node biopsy (SLNB) is usually performed. If the invasive focus in
the breast is small, sufﬁcient material may not be available for determi-
nation of receptor status. The sentinel node may be the only source of this
information, but this tissue is lost if the nodes are sent for intra-operative
assessment using one-step nucleic acid ampliﬁcation (OSNA). This study
examined OSNA results and treatment decisions in patients undergoing
mastectomy for DCIS.
Methods: Prospectively collected data was examined retrospectively in
patients who underwent mastectomy, SLNB and OSNA for DCIS, thought to
be without invasive disease, in a 12-month period.
Results: Of 53 patients, 38% had micro-invasive disease in the breast.
In 77% the node(s) were sent for OSNA. Micrometastasis was found
in 12% and macrometastasis in 7%, 1 patient had both. Of the OSNA
cases, frank invasive disease was found in 27% and microinvasive disease
in 7%.
Conclusions: When analysing sentinel nodes in patients undergoing
mastectomy for DCIS it may be prudent to send the node for formal his-
tology, not OSNA, so receptor status can be performed if micro-invasion is
found.
Cardiothoracic surgery
0254: CORONARY ARTERY BYPASS GRAFTING WITHOUT A LEFT ANTE-
RIOR DESCENDING ARTERY GRAFT e IS IT WORTH IT?
Andrew McGuigan*, Rory Beattie, Alastair Graham. Department of Cardiac
Surgery, Royal Victoria Hospital, Belfast, UK.
Introduction: Revascularising the left anterior descending (LAD)
artery with a left internal mammary artery (LIMA) graft is often cited
as the advantage of surgery over stenting. Little is known about
patients undergoing coronary artery bypass grafting (CABG) without LAD
graft.
Methods: Retrospectively analysis of our unit's experience of CABG
without LAD graft was undertaken. Patients having concomitant pro-
cedures aside from CABG were excluded. The National Death Registry was
accessed for survival data.
Results: Full data was available on 91 patients, representing 2% and 25% of
our total CABG and redo CABG caseloads respectively. Mean logistic
EuroSCOREwas 5.9 and in-hospital mortality 3.2%, with O/Emortality 0.54.
Reasons for lack of LAD graft and outcomes: n (%) 5 year survival LAD not
graftable 56 (61.5%) 80.7% No obstructive LAD disease 23 (25.3%) 91.1%
Patient previous LIMA to LAD graft 11 (12.1%) 90.0%.
Conclusions: Two percent of patients undergoing isolated CABG did not
receive an LAD graft. Although the peri-operative mortality is acceptable,
patients with ungraftable LAD disease had a 5-year survival almost
identical to those with complex disease randomised to PCI in the SYNTAX
trial (80.8%). This suggests that depending on clinical situation, either
treatment can be justiﬁed.
0422: STAGED HYBRID PROCEDURE FOR THE MANAGEMENT OF EMER-
GENCY LEAKING TYPE A AORTIC DISSECTION
June 1,2, Yi-Ling Low*,1, Sanjay Asopa 2, Suresh Babu 2, Sergei Dudnikov 2,
James Kuo 2. 1 Peninsula Medical School, Plymouth, UK; 2 South-West
Cardiothoracic Centre, Plymouth, UK.
Introduction: Acute Type A aortic dissection (ATAAD) is a surgical emer-
gency with a high mortality. Procedures including a frozen elephant trunk
have been suggested to manage them surgically. We describe our experi-
ence of a leaking ATAAD, which was managed successfully with a staged
hybrid procedure (SHP) by a multidisciplinary team approach (MDT).
Methods: 78 years old manwith leaking ATAAD underwent a 1st stage sur-
gical replacement of his ascending aorta under deep hypothermic circulatory
arrest with retrograde cerebral perfusion. Re-entry tear and site of the con-
tained rupture were identiﬁed just distal to the origin of the left subclavian
artery (LSA). Thiswasnotpossible to repair throughamediansternotomy. The
Interventional Radiologist performed the 2nd stage procedure by stenting the
leaking descending thoracic aneurysm with a Thoracic Endovascular Aortic
Stent followed by Amplatz device closure of his LSA to prevent an endoleak.
Results: SHP has made it possible to manage this complex ATAAD, which
cannot be treated by conventional surgery alone. The patient made an
excellent recovery with no neurological complications.
Conclusions: A multidisciplinary staged hybrid procedure provides an
effective treatment for an acute Type A aortic dissection complicated by a
contained rupture of the descending thoracic aorta.
0485: DOES PERI-OPERATIVE ANTI-COAGULATION IN THORACIC SUR-
GERY ALTER THE RATE OF POST-OPERATIVE BLEEDING?
Joshil Lodhia*, Krishna Prasad, Ashvini Menon, Eustace Fontaine,
Piotr Krysiak, Kandadai Rammohan.Wythenshawe Hospital, Manchester, UK.
Introduction: Patients undergoing thoracic surgery have a higher risk of
developing veno-thromboembolism (VTE). There are currently no guide-
lines for the use of perioperative anticoagulation in thoracic surgery. We
performed a prospective audit assessing the use of perioperative anti-
coagulation and its impact on postoperative bleeding.
Methods: Data for thoracic procedures was collected from drug charts,
surgical database and notes. The ﬁelds included: type of surgery, VTE score,
preoperative medications, use of perioperative anticoagulation, drain
output at 6, 12 and 24 hours post procedure and reoperations.
Results: 78 patients with an average VTE score of 19 (>14 is high risk)
thoracic surgery. 34 patients (Group A) received enoxaparin on post-
operative day 0, however 44 patients (Group B) did not receive anti-
coagulation. The mean bleeding rates were 389ml and 444ml in group A
and B respectively. During our audit period no patients were reopened for
bleeding and there were no in hospital postoperative VTEs.
Conclusions: There was no trend towards increased bleeding in the group
that received anticoagulation on the day of the operation. While keeping in
mind the small sample size in this study, one could make a case for
commencing anticoagulation on the night of the operation to reduce the
incidence of postoperative VTEs.
0559: WHO SURGICAL SAFETY CHECKLIST COMPLIANCE AFTER CORO-
NARY ARTERY BYPASS GRAFTING IN A LARGE TERTIARY CARE HOSPITAL
Maziar Khorsandi*,1, Laura Coad 2, Mark Jones 1, Kandadai Rammohan 1.
1Department of Cardio-Thoracic Surgery, Wythenshawe Hospital, Manchester,
UK; 2Clinical Audit, Wythenshawe Hospital, Manchester, UK.
Introduction: The WHO surgical safety checklist can prevent 40% of
inadvertent deaths and prevent almost 29% of major complications when
correctly adhered to. Failure to complete the checklist puts patient safety at
risk and has large ﬁnancial implications for NHS trusts.
Methods: We studied WHO checklist compliance for coronary artery
bypass grafting (CABG) at the cardio-thoracic surgery department of
Wythenshawe hospital. Advancing quality North West guidelines require
100% adherence with the WHO checklist. We completed the audit cycle
and a third audit to ensure sustained improvement in practice.
Results: We assessed the WHO checklist of 70 consecutive CABG pa-
tients during the year 2013 and found 25% compliance. The loop-closure
audit of 40 consecutive patients revealed 88% compliance. A third
prospective audit of 50 patients revealed 90% compliance with the WHO
checklist.
Conclusions: The correct completion of the WHO checklist is the re-
sponsibility of the surgeon. However, through completion of 3 audits we
observed over three-fold improvement in checklist completion when the
entire theatre team was given the responsibility in ensuring its correct
completion by surgeons. We recommend theatre team empowerment in
ensuring the correct completion of the checklist as well as regular auditing
as monitoring tool to assess checklist adherence.
0958: HOSPITAL STAYS POST CARDIAC SURGERY: WARFARIN VS DABI-
GATRAN
Amerdip Birring*, John Dark. Freeman Hospital, Newcastle, UK.
Introduction: To compare the hospital stays of patients anticoagulated
with warfarin versus dabigatran for the treatment of post-cardiac surgery
atrial ﬁbrillation (AF).
Method: All patients that developed new-onset AF following cardiac
surgery in our hospital were identiﬁed, using data from the National Adult
Cardiac Surgery Database. Patients that were not anticoagulant naïve or
required anticoagulation for multiple reasonswere excluded. The hospitals
electronic prescribing system was used to calculate time between initia-
tion of anticoagulation and discharge.
Results: 110 patients with AF post-cardiac surgery were identiﬁed. Of
these, 63 (57%) reverted to sinus rhythm within 48 hours of surgery and
therefore were not anticoagulated. 20 patients (18%) did not meet the
aforementioned criteria and were therefore excluded.
27 patients met the criteria for comparison. Of these 20 (74%) were anti-
coagulated with Warfarin, and 7 (26%) with Dabigatran. The average
hospital stay for patients' anticoagulated with Warfarin and Dabigatran
was 3.5 and 2.7 days, respectively.
Conclusions: Anticoagulation with dabigatran results in shorter hospital
stays. However, warfarin is still much more likely to be prescribed than
dabigatran. This may be because doctors are not conﬁdent in prescribing
this relatively new drug. More education is necessary in order to increase
utilization of Dabigatran.
1173: PERIOPERATIVE ASPIRIN IN THORACIC SURGERY: AN AUDIT OF
DOCUMENTATION AND USE
Simon Tallowin*, Babu Naidu. Heart of England Foundation Trust, West
Midlands, UK.
Introduction: This audit aimed to identify current peri-operative use of
aspirin in a regional thoracic surgery department and how clearly this is
communicated to patients.
Methods: Patients taking aspirin admitted for elective thoracic surgery
were identiﬁed from electronic records. Medical records and pre-operative
clinic letter(s) were assessed to determine the indication for aspirin use,
and whether a clear plan for its peri-operative use had been explained to
the patient in writing. Inconsistencies between pre-operative letters from
clinicians and pre-operative assessment clinic recommendations to the
patient were identiﬁed.
Results: 41 patients were identiﬁed over a 4-month period. Overall, 74%
of patients had no clear plan documented in pre-operative clinic letter(s).
With the exception of those on dual therapy for coronary stents (100%),
the documentation for high-risk patients was poor: Coronary stent
(single agent e 20%); Secondary prevention of CVA/TIA (10%); Secondary
prevention of MI (0%). There was also inconsistency in practice e 84% of
patients (on single therapy) had aspirin stopped pre-operatively,
including 40% of patients with coronary stents, contrary to current
guidelines.
Conclusions: This audit revealed inconsistent documentation and peri-
operative use of aspirin in the department. Further work to clarify
appropriate aspirin use and improve written communication is ongoing.
1270: OUTCOMES OF THORACIC SURGICAL INTERVENTIONS ON ECMO
PATIENTS: A 4 YEAR EXPERIENCE
Pouya Yousseﬁ*, Tom Doyle, Karen Harrison-Phipps, John Pilling,
Juliet King, Tom Routledge, Loic Lang-Lazdunski, Guy Glover,
Chris Langrish, Nicholas Ioannou, Chris Meadows, Nicholas Barrett. Guys
& St. Thomas' NHS Trust, London, UK.
Introduction: Extra-corporeal-membrane-oxygenation (ECMO) is used in
severe respiratory failure to maintain adequate gas exchange. These
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